Trial Profile
A Study Assessing the Effect of Fingolimod Therapy on Parameters of Cardiovascular Autonomic Modulation at Different Timepoints in Relapsing-Remitting Multiple Sclerosis Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2017
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 28 Jul 2017 New trial record
- 27 Jun 2017 Results presented at the 3rd Congress of the European Academy of Neurology.